ATE36531T1 - Verfahren zur herstellung von abgesetzten, basischen piroxicam-salzen auf einem pharmazeutisch annehmbaren traeger. - Google Patents

Verfahren zur herstellung von abgesetzten, basischen piroxicam-salzen auf einem pharmazeutisch annehmbaren traeger.

Info

Publication number
ATE36531T1
ATE36531T1 AT84302666T AT84302666T ATE36531T1 AT E36531 T1 ATE36531 T1 AT E36531T1 AT 84302666 T AT84302666 T AT 84302666T AT 84302666 T AT84302666 T AT 84302666T AT E36531 T1 ATE36531 T1 AT E36531T1
Authority
AT
Austria
Prior art keywords
piroxicam
acceptable carrier
preparation
pharmaceutically acceptable
deposited
Prior art date
Application number
AT84302666T
Other languages
English (en)
Inventor
Melvin Mackenzie Noseworthy
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE36531T1 publication Critical patent/ATE36531T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/04—1,3-Thiazines; Hydrogenated 1,3-thiazines
    • C07D279/08—1,3-Thiazines; Hydrogenated 1,3-thiazines condensed with carbocyclic rings or ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Stabilization Of Oscillater, Synchronisation, Frequency Synthesizers (AREA)
  • Distillation Of Fermentation Liquor, Processing Of Alcohols, Vinegar And Beer (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
AT84302666T 1983-04-25 1984-04-19 Verfahren zur herstellung von abgesetzten, basischen piroxicam-salzen auf einem pharmazeutisch annehmbaren traeger. ATE36531T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48830383A 1983-04-25 1983-04-25
EP84302666A EP0123520B1 (de) 1983-04-25 1984-04-19 Verfahren zur Herstellung von abgesetzten, basischen Piroxicam-Salzen auf einem pharmazeutisch annehmbaren Träger

Publications (1)

Publication Number Publication Date
ATE36531T1 true ATE36531T1 (de) 1988-09-15

Family

ID=23939186

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84302666T ATE36531T1 (de) 1983-04-25 1984-04-19 Verfahren zur herstellung von abgesetzten, basischen piroxicam-salzen auf einem pharmazeutisch annehmbaren traeger.

Country Status (28)

Country Link
EP (1) EP0123520B1 (de)
JP (1) JPS59205375A (de)
KR (1) KR840008345A (de)
AT (1) ATE36531T1 (de)
AU (1) AU548451B2 (de)
BG (1) BG40810A3 (de)
CA (1) CA1213220A (de)
CS (1) CS246078B2 (de)
DD (1) DD219672A5 (de)
DE (1) DE3473454D1 (de)
DK (1) DK165168C (de)
EG (1) EG17887A (de)
ES (1) ES531866A0 (de)
FI (1) FI82377C (de)
GR (1) GR81938B (de)
GT (1) GT198404085A (de)
HU (1) HU194217B (de)
IE (1) IE57327B1 (de)
IL (1) IL71598A (de)
MX (1) MX159889A (de)
NO (1) NO165177C (de)
NZ (1) NZ207930A (de)
PH (1) PH18864A (de)
PL (1) PL144064B1 (de)
PT (1) PT78473B (de)
RO (1) RO88420A (de)
YU (1) YU44232B (de)
ZA (1) ZA843013B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4582831A (en) * 1984-11-16 1986-04-15 Pfizer Inc. Anti-inflammatory polymorphic monoethanolamine salt of N-(2-pyridyl)-2-methyl-4-hydroxy-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide compound, composition, and method of use therefor
HU200926B (en) * 1988-10-28 1990-09-28 Egyt Gyogyszervegyeszeti Gyar Pharmaceutical composition comprising piroxicam and lactose for use in making tablets or capsules
GB9212450D0 (en) * 1992-06-11 1992-07-22 Indena Spa New derivatives of non-steroidal anti-inflammatory,analgesic and/or antipyretic substances,their use and pharmaceutical formulations containing them
KR100446829B1 (ko) * 2002-02-20 2004-09-04 한국유나이티드제약 주식회사 가용화된 피록시캄을 함유한 확산형 정제의 조성물 및그의 제조방법
KR100791160B1 (ko) * 2006-05-30 2008-01-02 조선대학교산학협력단 멜록시캄의 에탄올아민염 및 이를 함유하는 약제학적조성물
JP2010083826A (ja) * 2008-10-01 2010-04-15 Nihon Generic Co Ltd オキシカム系化合物を含む固形製剤を製造する方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4434164A (en) * 1981-06-01 1984-02-28 Pfizer Inc. Crystalline benzothiazine dioxide salts
IN160683B (de) * 1981-06-01 1987-07-25 Pfizer

Also Published As

Publication number Publication date
AU2716084A (en) 1984-11-01
PT78473B (en) 1986-08-28
DK165168B (da) 1992-10-19
GT198404085A (es) 1985-10-16
DE3473454D1 (en) 1988-09-22
ES8505365A1 (es) 1985-05-16
DK204484D0 (da) 1984-04-24
YU44232B (en) 1990-04-30
IE57327B1 (en) 1992-07-29
IE840982L (en) 1984-10-25
PL144064B1 (en) 1988-04-30
NO165177B (no) 1990-10-01
FI841604A (fi) 1984-10-26
CA1213220A (en) 1986-10-28
JPH0251527B2 (de) 1990-11-07
CS246078B2 (en) 1986-10-16
EP0123520A1 (de) 1984-10-31
NO841611L (no) 1984-10-26
IL71598A (en) 1987-01-30
MX159889A (es) 1989-09-27
PH18864A (en) 1985-10-21
KR840008345A (ko) 1984-12-14
IL71598A0 (en) 1984-07-31
EG17887A (en) 1991-03-30
DK204484A (da) 1984-10-26
DD219672A5 (de) 1985-03-13
HUT34023A (en) 1985-01-28
JPS59205375A (ja) 1984-11-20
DK165168C (da) 1993-03-08
PL247378A1 (en) 1985-03-26
BG40810A3 (en) 1987-02-16
FI82377C (fi) 1991-03-11
GR81938B (de) 1984-12-12
EP0123520B1 (de) 1988-08-17
FI841604A0 (fi) 1984-04-24
AU548451B2 (en) 1985-12-12
RO88420A (ro) 1986-01-30
FI82377B (fi) 1990-11-30
ZA843013B (en) 1985-12-24
HU194217B (en) 1988-01-28
ES531866A0 (es) 1985-05-16
NO165177C (no) 1991-01-09
NZ207930A (en) 1986-09-10
PT78473A (en) 1984-05-01
YU72484A (en) 1988-04-30

Similar Documents

Publication Publication Date Title
ES8505519A1 (es) Un procedimiento para la preparacion de 14-fluoromorfinanos utiles como analgesicos, narcoticos y-o agentes anorexicos.
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
MY101934A (en) Composition useful for producing analgesia
NO874733D0 (no) Fremgangsmaate ved fremstilling av et salt av diclofenac med en cyklisk organisk base.
ATE36531T1 (de) Verfahren zur herstellung von abgesetzten, basischen piroxicam-salzen auf einem pharmazeutisch annehmbaren traeger.
IT1232303B (it) Composti di diammina e loro sali, procedimenti per la loro preparazio ne e composizioni farmaceutiche contenenti detti composti e i loro sa li
ATE29026T1 (de) Sulfonylharnstoff-derivate, verfahren zur herstellung und pharmazeutische zusammenstellungen die sie enthalten.
PT74721B (de) Oxindol-derivate verfahren zu ihrer herstellung und sie enthaltende arzneimittel mit neuroanaboler wirkung
ATE45090T1 (de) Pharmazeutische zusammensetzung in oralen darreichungsformen.
DE3266072D1 (en) Method for the oral administration of substances in the form of liposomes, and relative pharmaceutical compositions
ATE73326T1 (de) Verwendung von l-carnitin zur herstellung eines arzneimittels zur behandlung von toxischen effekten, induziert durch die inhalation von halotan und anderen halogen enthaltenden allgemeinen anaesthetika.
KR890005107A (ko) 약제 제조를 위한 특정 6-머캅토푸린의 용도 및 이 약제의 제조방법

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee